GeneMedicine adds element of uncertainty

Gene therapy products have entered the clinic, but the field still faces basic issues of how to deliver genes to specific tissues and how to express the genes appropriately once they have been delivered. GeneMedicine Inc. staked its claim to one delivery method when it announced last week the issuance of patents in the U.S. and Europe covering its cationic lipid technology.

GMED said it has no plans to license

Read the full 693 word article

How to gain access

Continue reading with a
two-week free trial.